A multicentre, prospective clinical evaluation study for analyzing RAS mutational status utilizing plasma circulating tumor DNA in patients with metastatic colorectal cancer

被引：0
|
作者：
Kagawa, Y. [1 ]
Kato, T. [2 ]
Bando, H. [3 ]
Akagi, K. [4 ]
Denda, T. [5 ]
Nishina, T. [6 ]
Komatsu, Y. [7 ]
Oki, E. [8 ]
Kudo, T. [9 ]
Yamanaka, T. [10 ]
Yoshino, T. [11 ]
机构：
[1] Kansai Rosai Hosp, Dept Gastrointestinal Surg, Amagasaki, Hyogo, Japan
[2] Natl Hosp Org Osaka Natl Hosp, Dept Surg, Osaka, Japan
[3] Natl Canc Ctr Hosp East, Dept Gastrointestinal Oncol, Kashiwa, Chiba, Japan
[4] Saitama Canc Ctr, Ina, Saitama, Japan
[5] Chiba Canc Ctr, Chiba, Japan
[6] Shikoku Canc Ctr, Matsuyama, Ehime, Japan
[7] Hokkaido Univ Hosp, Div Canc Ctr, Digest Internal Med, Sapporo, Hokkaido, Japan
[8] Kyushu Univ, Grad Sch Med Sci, Dept Surg, Higashi Ku, Fukuoka, Japan
[9] Osaka Univ, Grad Sch Med, Suita, Osaka, Japan
[10] Yokohama City Univ, Sch Med, Yokohama, Kanagawa, Japan
[11] Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
O - 005
引用
收藏
页数：2
相关论文
共 50 条
  • [1] A multicentre, prospective study of plasma circulating tumour DNA test for detecting RAS mutation in patients with metastatic colorectal cancer
    Hideaki Bando
    Yoshinori Kagawa
    Takeshi Kato
    Kiwamu Akagi
    Tadamichi Denda
    Tomohiro Nishina
    Yoshito Komatsu
    Eiji Oki
    Toshihiro Kudo
    Hiroshi Kumamoto
    Takeharu Yamanaka
    Takayuki Yoshino
    British Journal of Cancer, 2019, 120 : 982 - 986
  • [2] A multicentre, prospective study of plasma circulating tumour DNA test for detecting RAS mutation in patients with metastatic colorectal cancer
    Bando, Hideaki
    Kagawa, Yoshinori
    Kato, Takeshi
    Akagi, Kiwamu
    Denda, Tadamichi
    Nishina, Tomohiro
    Komatsu, Yoshito
    Oki, Eiji
    Kudo, Toshihiro
    Kumamoto, Hiroshi
    Yamanaka, Takeharu
    Yoshino, Takayuki
    BRITISH JOURNAL OF CANCER, 2019, 120 (10) : 982 - 986
  • [3] Correction: A multicentre, prospective study of plasma circulating tumour DNA test for detecting RAS mutation in patients with metastatic colorectal cancer
    Hideaki Bando
    Yoshinori Kagawa
    Takeshi Kato
    Kiwamu Akagi
    Tadamichi Denda
    Tomohiro Nishina
    Yoshito Komatsu
    Eiji Oki
    Toshihiro Kudo
    Hiroshi Kumamoto
    Takeharu Yamanaka
    Takayuki Yoshino
    British Journal of Cancer, 2020, 122 : 1271 - 1271
  • [4] Clinical Utility of Analyzing Circulating Tumor DNA in Patients with Metastatic Colorectal Cancer
    Nakamura, Yoshiaki
    Yoshino, Takayuki
    ONCOLOGIST, 2018, 23 (11): : 1310 - 1318
  • [5] A multicentre, prospective study of plasma circulating tumour DNA test for detecting RAS mutation in patients with metastatic colorectal cancer (vol 120, pg 982, 2020)
    Bando, Hideaki
    Kagawa, Yoshinori
    Kato, Takeshi
    Akagi, Kiwamu
    Denda, Tadamichi
    Nishina, Tomohiro
    Komatsu, Yoshito
    Oki, Eiji
    Kudo, Toshihiro
    Kumamoto, Hiroshi
    Yamanaka, Takeharu
    Yoshino, Takayuki
    BRITISH JOURNAL OF CANCER, 2020, 122 (08) : 1271 - 1271
  • [6] RAS mutation analysis in circulating tumor DNA from patients with metastatic colorectal cancer: the AGEO RASANC prospective multicenter study
    Bachet, J. B.
    Bouche, O.
    Taieb, J.
    Dubreuil, O.
    Garcia, M. L.
    Meurisse, A.
    Normand, C.
    Gornet, J. M.
    Artru, P.
    Louafi, S.
    Bonnetain, F.
    Thirot-Bidault, A.
    Baumgaertner, I
    Coriat, R.
    Tougeron, D.
    Lecomte, T.
    Mary, F.
    Aparicio, T.
    Marthey, L.
    Taly, V
    Blons, H.
    Vernerey, D.
    Laurent-Puig, P.
    ANNALS OF ONCOLOGY, 2018, 29 (05) : 1211 - 1219
  • [7] Circulating tumor DNA to personalize treatment in patients with RAS mutant metastatic colorectal cancer
    Paola, G.
    Loreni, F.
    Raimondi, C.
    Chiara, N.
    Angela, G.
    Federica, U.
    Enrico, C.
    CLINICAL & EXPERIMENTAL METASTASIS, 2018, 35 (03) : 187 - 187
  • [8] Circulating tumor DNA extended RAS mutational analysis as a surrogate of mutational status of tumor samples in metastatic colorectal cancer and its impact on patient selection for anti-EGFR therapy
    Grasselli, J.
    Elez, E.
    Caratu, G.
    Matito, J.
    Santos, C.
    Macarulla, T.
    Vidal, J.
    Garcia, M.
    Vieitez, J. M.
    Paez, D.
    Falco, E.
    Lopez Lopez, C.
    Aranda, E.
    Jones, F.
    Sikri, V.
    Nuciforo, P.
    Dienstmann, R.
    Montagut, C.
    Tabernero, J.
    Azuara, D.
    Salazar, R.
    Vivancos, A.
    ANNALS OF ONCOLOGY, 2016, 27 : 127 - 127
  • [9] Evaluation of RAS Mutational Status in Liquid Biopsy to Monitor Disease Progression in Metastatic Colorectal Cancer Patients
    Lastraioli, Elena
    Bettiol, Alessandra
    Iorio, Jessica
    Limatola, Elvira
    Checcacci, Daniele
    Parisi, Erica
    Bianchi, Cristina
    Arcangeli, Annarosa
    Iannopollo, Mauro
    Di Costanzo, Francesco
    Di Lieto, Marco
    CELLS, 2023, 12 (11)
  • [10] Pretreatment Plasma Circulating Tumor DNA RAS/BRAF Mutational Status in Refractory Metastatic Colorectal Cancer Patients Who Are Candidates for Anti-EGFR Rechallenge Therapy: A Pooled Analysis of the CAVE and VELO Clinical Trials
    Ciardiello, Davide
    Napolitano, Stefania
    Famiglietti, Vincenzo
    Esposito, Lucia
    De Falco, Vincenzo
    Di Liello, Alessandra
    Avallone, Antonio
    Maiello, Evaristo
    Pietrantonio, Filippo
    Cremolini, Chiara
    Zampino, Maria Giulia
    Fazio, Nicola
    Troiani, Teresa
    Martinelli, Erika
    Ciardiello, Fortunato
    Martini, Giulia
    CANCERS, 2023, 15 (07)
12345